Who are the inventors and entrepreneurs in Arizona who are ready to stand in the shoes of Bill Gates or Steve Jobs?
|Posted by [email protected] on October 16, 2011 at 10:50 PM|
California Governor, Jerry Brown, declares October 16, 2011 Steve Jobs Day in honor of Jobs’ amazing contribution to our world’s technology.
Steve Jobs was often thought of as a modern day Benjamin Franklin or Thomas Edison during his life, an archetypal American inventor of the most revolutionary kind who was able to not only create new products that changed people's lives, but to also market them with equal zest.
There's no doubt that Jobs deserves a front-row seat in the pantheon of great inventors and entrepreneurs in history. In the 35 years since he founded Apple, he created the Apple II, the iMac, iPod, iPhone and most recently, the iPad – five products that transformed the technological, music, film, TV, gaming and publishing industries. Few could claim to have even developed a single such product.
In honor of Steve Jobs I wanted to share with you some of the amazing talent in Arizona and what is happening with scientists, inventors and entrepreneurs. Have you heard the name Michael Manson, Paul Keim, Tom Kanacek or David Engelthaler?
If not . . . you will soon!
These names are among the ones that will be added alongside Steve Jobs.
I believe Tom Janacek, David Calle and Michael Manson are well on their way to addressing issues relating to minimizing our carbon footprint, dependence on foreign oil and cost effective transportation.
Michael Manson co-founded PETsMART, the most successful pet product retailer in the world. David Calley co-founded Southwest Windpower, the world’s largest supplier of mall-scale wind turbines for homes, businesses and industry.
Manson and Calley met in Flagstaff, Arizona in 2003, and began discussing commercialization opportunities for the new motor architecture Calley invented. In 2006, Tom Janacek joined the two, focusing his 13 years of prototyping expertise on building an entirely new class of motors.
Passionate about the technology’s potential and eager to bring it to market, Manson, Calley and Janacek spent two tireless years working in Janacek’s garage developing prototypes. In 2008, independent testing of the prototypes validated the dramatic benefits of the technology and proved manufacturability of the motors.
Me continues to attract a world-class team of engineers and managers leading the Company into the future. Learn more about Me’s remarkable team.
Who is making is making advances in cartilage and bone repair, new technologies to address a variety of orthopedic conditions for arthritis, fractures and bone cysts?
BioVeteria Life Sciences in Prescott, AZ is working with Dr. Anastassiades a Professor of Medicine and Biochemistry and Head of the Division of Rheumatology at Queen’s University in Kingston, Ontario, Canada and the Canadian Arthritis Network. CAN is one of Canada’s a federally funded National Centres of Excellence and is a single point of contact for more than 200 leading Canadian arthritis researchers and clinician scientists.
CAN works in close collaboration with its Consumer Advisory Council, comprised of people living with arthritis, to develop R&D programs that make a difference, including R&D programs that facilitate technology transfer and commercialization of new discoveries. For more information, visit www.arthritisnetwork.ca. Dr. Anastassiades has been involved in characterizing glucosamine derivatives for their effects on bone and cartilage and is the inventor of patents related to the technology.
Who is developing improved treatments and prevention of infectious diseases to prevent the spread of life-threatening super bugs?
PathoGene in Flagstaff Arizona is a biosciences is a digital pathology services company created by industry leading molecular pathologists to fill the growing need for advanced digital technology in drug development and medical devices. The founding members are Technical Resource Management, Inc. (TRM), Thomas E. Vorpahl, William P. Gibbs, Paul S. Keim, and David M. Engelthaler.
PathoGene is developing a rapid molecular diagnostic that should significantly improve the diagnosis MRSA and Valley Fever. MRSA is one of the most common hospital acquired infections, and is particularly problematic given the high degree of antibiotic resistance that MRSA has developed. PathoGene is developing rapid novel molecular diagnostics that both identify the bacteria as well as the drug resistance profile. This will provide physicians with better and quicker information that will provide for earlier intervention with appropriate drugs.
Valley Fever is a fungal respiratory disease endemic to the desert southwest. It is often misdiagnosed as community acquired pneumonia and treated with antibiotics, which are ineffective against a fungal infection. Given the relatively poor diagnostic tools that are currently available, the average time for a patient to be diagnosed with Valley Fever after first seeking care is around 5 months.
The Arizona Chamber of Commerce and Industry proposes that we ask the following of our policy leaders to encourage and protect technology and economic development in Arizona:
• Enhance Arizona’s global competitiveness as a business location.
• Retain and strengthen the state’s existing high-wage industries.
• Strongly promote economic diversification and the growth of emerging sectors, including renewable energy, health care, education, biotech, and other technologies.
• Advocate for policies that encourage job retention and creation.
• Promote broad awareness of Arizona’s economic performance and the importance of key technology sectors to the state’s future economic success.
• Position Arizona employers to compete in the global economy by ensuring ready access to a skilled workforce, modern infrastructure, capital, consistent and predictable state budgetary, tax, and regulatory processes, and world-class research and development.
Several goals addressing the public/private partnership between Arizona’s research institutions and the private sector are:
Promote University Research and Technology Commercialization: Increase private sector funding of research and development at state universities. Increase receipts of federal research grants. Facilitate the ownership of intellectual property rights resulting from joint research efforts. Foster the commercialization of innovations developed in universities by industries in Arizona.
Stimulate Early-Stage Capital Formation: Encourage innovative solutions that increase access to capital by start-up and early-stage technology ventures across the state in order to support the development of new businesses and increase economic diversification.
Encourage Financial Support for Statewide Economic Development Initiatives: Maintain funding for programs that enhance Arizona’s ability to retain and attract businesses and expand research and development capacity.
Increase International Investment in Arizona: Support efforts to attract foreign direct investment to Arizona companies in order to sustain growth and create jobs.